biotech / news / / Devdiscourse
The U.S. FDA has announced plans to seek input on repurposing approved drugs.
FDA plans to seek public input on repurposing approved drugs for wider disease applications.
KEY POINTS
- Lundbeck raised its 2026 sales forecasts due to U.S. demand and delayed generic competition.
- Roche received a second European regulatory approval for its Alzheimer's blood test developed with Eli Lilly.
- Cellular Intelligence, backed by Mark Zuckerberg, acquired a Parkinson's cell therapy from Novo Nordisk.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →